Effect of methotrexate alone and in combination with vincristine on craniofacial morphology in growing rats

Acta Odontologica Scandinavica

Volumn 57, Issue 5, 1999, Pages 271-276

  Karsila, Susanna ^a   Salmi, Toivo T ^b   Rönning, Olli ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Adverse effect; Craniofacial growth; Methotrexate; Rats; Vincristine

Indexed keywords

METHOTREXATE; VINCRISTINE;

ANIMAL EXPERIMENT; ARTICLE; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL MORPHOLOGY; DOSE RESPONSE; DRUG EFFECT; GROWTH RETARDATION; NONHUMAN; RAT; SEX DIFFERENCE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; MALE; MAXILLOFACIAL DEVELOPMENT; METHOTREXATE; RATS; RATS, LONG-EVANS; VINCRISTINE;

EID: 0032712014     PISSN: 00016357     EISSN: None     Source Type: Journal    
DOI: 10.1080/000163599428698     Document Type: Article

References (16)

1. Balis FM, Holcenberg JS, Poplack DG. General principles of chemotherapy. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 3rd ed. Philadelphia: Lippincott-Raven; 1997. p. 215-72.
2. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg 1984;66A:602-7.
3. Wheeler DL, Vander Griend RA, Wronski TJ, Miller GJ, Keith EE, Graves JE. The short- and long-term effects of methotrexate on the rat skeleton. Bone 1995;16:215-21.
4. Atkinson SA, Fraher L, Gundberg CM, Andrew M, Pai M, Barr RD. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 1989;114:793-800.
5. Schunior A, Mullenix PJ, Zengel AE, Landy H, Howes A, Tarbell NJ. Radiation effects of growth are altered in rats by prednisolone and methotrexate. Pediatr Res 1994;35:416-23.
6. Karsila S, Salmi TT, Helenius H, Rönning O. Craniofacial growth of immature rats following administration of VCR and doxorubicin. Manuscript, 1998.
7. Knorr DW, Vanha-Perttula T, Lippseti MB. Structure and function of rat testis through pubescence. Endocrinology 1970; 86:1298-304.
8. Sorosky JI, Sood AK, Buekers TE. The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am 1997;24:591-9.
9. Näsman M, Hammarström L. Influence of the antineoplastic agent cyclophosphamide on dental development in rat molars. Acta Odontol Scand 1996;54:287-94.
10. Pohjanvirta R, Unkila M, Tuomisto J. Comparative acute lethality of 2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentacholorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachohlorodibenzo-p-dioxin in the most TCDD-susccptible and the most TCDD-resistant rat strain. Pharmacol Toxicol 1993; 73:52-6.
11. Baer MJ. Patterns of growth of the skull as revealed by vital staining. Human Biol 1954;26:80-126.
12. Katz JA, Pollock BH, Jacaruso D, Morad A. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr 1993;123:546-52.
13. Moell C, Marky I, Hovi L, Kristinsson J, Rix M, Moe PJ, et al. Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med Pediatr Oncol 1994;22:375-9.
14. Van der Does-VandenBerg A, Yaan GAM, de Weerden JF, van Hählen K, Weel-Sipman M, van Veerman AJP. Late effects among long-term survivors of childhood acute leukemia in The Netherlands: a Dutch childhood leukemia study group report. Pediatr Res 1995;38:802-7.
15. Ogilvy-Stuart AL, Shalet SM. Effect of chemotherapy on growth. Acta Paediatr Suppl 1995;411:52-6.
16. Ilveskoski I, Saarinen UM, Wiklund T, Sipilä I, Mäkipernaa A, Perkkiö M, et al. Growth impairment and growth hormone therapy in children treated for malignant brain tumors. Eur J Pediatr 1997;156:764-9.